Aperio Group’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $575K | Buy |
30,763
+784
| +3% | +$14.7K | ﹤0.01% | 1898 |
|
2020
Q3 | $509K | Buy |
29,979
+446
| +2% | +$7.57K | ﹤0.01% | 1803 |
|
2020
Q2 | $688K | Buy |
29,533
+595
| +2% | +$13.9K | ﹤0.01% | 1603 |
|
2020
Q1 | $243K | Sell |
28,938
-2,920
| -9% | -$24.5K | ﹤0.01% | 2014 |
|
2019
Q4 | $312K | Buy |
31,858
+7,263
| +30% | +$71.1K | ﹤0.01% | 2049 |
|
2019
Q3 | $234K | Sell |
24,595
-10,004
| -29% | -$95.2K | ﹤0.01% | 2121 |
|
2019
Q2 | $411K | Sell |
34,599
-12,999
| -27% | -$154K | ﹤0.01% | 1888 |
|
2019
Q1 | $838K | Buy |
47,598
+1,076
| +2% | +$18.9K | ﹤0.01% | 1452 |
|
2018
Q4 | $807K | Buy |
46,522
+5,653
| +14% | +$98.1K | ﹤0.01% | 1424 |
|
2018
Q3 | $609K | Sell |
40,869
-2,096
| -5% | -$31.2K | ﹤0.01% | 1667 |
|
2018
Q2 | $683K | Sell |
42,965
-8,504
| -17% | -$135K | ﹤0.01% | 1596 |
|
2018
Q1 | $731K | Buy |
51,469
+6,819
| +15% | +$96.8K | ﹤0.01% | 1497 |
|
2017
Q4 | $626K | Sell |
44,650
-3,252
| -7% | -$45.6K | ﹤0.01% | 1597 |
|
2017
Q3 | $685K | Sell |
47,902
-3,483
| -7% | -$49.8K | ﹤0.01% | 1500 |
|
2017
Q2 | $809K | Buy |
51,385
+14,682
| +40% | +$231K | 0.01% | 1352 |
|
2017
Q1 | $506K | Buy |
36,703
+22,560
| +160% | +$311K | ﹤0.01% | 1537 |
|
2016
Q4 | $250K | Sell |
14,143
-1,666
| -11% | -$29.4K | ﹤0.01% | 1883 |
|
2016
Q3 | $305K | Buy |
15,809
+2,602
| +20% | +$50.2K | ﹤0.01% | 1701 |
|
2016
Q2 | $258K | Sell |
13,207
-2,735
| -17% | -$53.4K | ﹤0.01% | 1728 |
|
2016
Q1 | $329K | Buy |
15,942
+2,986
| +23% | +$61.6K | ﹤0.01% | 1601 |
|
2015
Q4 | $266K | Sell |
12,956
-748
| -5% | -$15.4K | ﹤0.01% | 1685 |
|
2015
Q3 | $234K | Buy |
13,704
+1,528
| +13% | +$26.1K | ﹤0.01% | 1690 |
|
2015
Q2 | $227K | Sell |
12,176
-536
| -4% | -$9.99K | ﹤0.01% | 1789 |
|
2015
Q1 | $243K | Buy |
+12,712
| New | +$243K | ﹤0.01% | 1700 |
|